Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.
Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Julie N. Graff(Oregon Health & Science University), Jessica A. Blank(Oregon Health & Science University)
PubMed
December 17, 2018
Cited by 23
Related Papers
Immune Checkpoint Inhibitors in Organ Transplant Patients
|Journal of Immunotherapy|2017|150
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
|Journal for ImmunoTherapy of Cancer|2020|120
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia
|JACC CardioOncology|2023|107
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib
|Cancer|2018|86
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
|Haematologica|2022|73